RiskMastery's Breakout Stocks - CSBTF EditionWelcome to RiskMastery's Breakout Stocks - Stocks with breakout potential.
In this edition, we'll be looking at OTC:CSBTF ...
I believe this code is at a point of potential volatility.
If price can hold above $6.03 ... Bullish potential may be unlocked.
My key upside targets include:
Kuros Biosciences Ltd.
No trades
No trades
Peers for comparison
0.18 CHF
2.12 M CHF
121.30 M CHF
28.66 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Christopher T. Fair
Website
Headquarters
Schlieren
Founded
2000
IPO date
Oct 29, 2002
ISIN
CH0325814116
FIGI
BBG000BX18D1
Identifiers
ISIN CH0325814116
Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals, and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment offers Fibrin-PTH, a drug-biologic combination which promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and by increasing the lifespan of bone-forming cells. The Legacy portfolio segment is involved in all other products that do not belong to the group's core business strategy. The company was founded by Didier Cowling in 2000 and is headquartered in Schlieren, Switzerland.
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
Today, KURN trades at 19.54 CHF.
For broader market analysis, dive into the technicals on the Kuros Biosciences Ltd. stock price chart and read the latest KURN news:
– Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026
– KURN: Achieved 45% revenue growth and first-half profitability, driven by U.S. adoption and operational scale
– KURN: Record revenue growth and profitability achieved, with strong outlook for continued expansion
For broader market analysis, dive into the technicals on the Kuros Biosciences Ltd. stock price chart and read the latest KURN news:
– Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026
– KURN: Achieved 45% revenue growth and first-half profitability, driven by U.S. adoption and operational scale
– KURN: Record revenue growth and profitability achieved, with strong outlook for continued expansion
Markets don't sleep, here's what's going on with KURN at the moment:
– Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026
– KURN: Achieved 45% revenue growth and first-half profitability, driven by U.S. adoption and operational scale
– KURN: Record revenue growth and profitability achieved, with strong outlook for continued expansion
See more updates in real-time with our News Flow.
– Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026
– KURN: Achieved 45% revenue growth and first-half profitability, driven by U.S. adoption and operational scale
– KURN: Record revenue growth and profitability achieved, with strong outlook for continued expansion
See more updates in real-time with our News Flow.
Kuros Biosciences Ltd. is scheduled to release its next earnings report on Mar 3, 2027.
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
KURN stock is 6.17% volatile and has beta coefficient of 0.46.
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like KURN are typically less volatile than smaller companies
Track every detail on Kuros Biosciences Ltd. stock chart and check out the list of the most volatile stocks — is Kuros Biosciences Ltd. there?
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like KURN are typically less volatile than smaller companies
Track every detail on Kuros Biosciences Ltd. stock chart and check out the list of the most volatile stocks — is Kuros Biosciences Ltd. there?
To understand the KURN stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −5.33%
– 1 week — −6.51%
– 1 month — +3.06%
KURN all-time low was 1.12 CHF (Apr 26, 2023), and its highest price is 12,561.04 CHF (Apr 25, 2007). Find more dynamics in the Stock Heatmap and on the Kuros Biosciences Ltd. stock chart.
– 1 day — −5.33%
– 1 week — −6.51%
– 1 month — +3.06%
KURN all-time low was 1.12 CHF (Apr 26, 2023), and its highest price is 12,561.04 CHF (Apr 25, 2007). Find more dynamics in the Stock Heatmap and on the Kuros Biosciences Ltd. stock chart.
Kuros Biosciences Ltd. market capitalization is 827.60 M, representing the total value of all its outstanding shares (price × shares outstanding).
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Kuros Biosciences Ltd. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Kuros Biosciences Ltd. stacks up against other companies
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Kuros Biosciences Ltd. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Kuros Biosciences Ltd. stacks up against other companies
The safest way to buy Kuros Biosciences Ltd. stocks is through a reliable broker. Create an account, fund it, and place a buy order.
You can trade KURN directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
You can trade KURN directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 8, 2026, the company has 178 employees.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Investing in Kuros Biosciences Ltd. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.
First, study Kuros Biosciences Ltd. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our KURN technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell
Combine fundamental and technical analysis for better results.
First, study Kuros Biosciences Ltd. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our KURN technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell
Combine fundamental and technical analysis for better results.
Kuros Biosciences Ltd. stock ticker depends on the exchange where it’s listed. On the SIX, its primary exchange, Kuros Biosciences Ltd. stocks trade under the symbol KURN.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
Kuros Biosciences Ltd. revenue for the last half-year amounts to 74.69 M CHF despite the estimated figure of 73.56 M CHF. In the next half-year revenue is expected to reach 91.15 M CHF.
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous periods and year-over-year data
– Track trends: One half-year matters less than consistent performance
Follow other essential metrics in Kuros Biosciences Ltd. financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous periods and year-over-year data
– Track trends: One half-year matters less than consistent performance
Follow other essential metrics in Kuros Biosciences Ltd. financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track Kuros Biosciences Ltd. financials in yearly and quarterly reports right on TradingView.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
KURN net income for the last half-year is 3.47 M CHF, while the half-year before that showed 3.65 M CHF of net income which accounts for −5.04% change.
How to read this data:
– Track changes: Compare net income across periods to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one period: Consistency matters more than a single result
Follow other essential metrics in Kuros Biosciences Ltd. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
How to read this data:
– Track changes: Compare net income across periods to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one period: Consistency matters more than a single result
Follow other essential metrics in Kuros Biosciences Ltd. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Kuros Biosciences Ltd. does not currently pay dividends to its shareholders.
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
KURN reached its all-time high of 12,561.04 CHF on Apr 25, 2007. Its all-time low was 1.12 CHF and was reached on Apr 26, 2023.
Explore the Kuros Biosciences Ltd. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Explore the Kuros Biosciences Ltd. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Kuros Biosciences Ltd. EBITDA is 11.55 M CHF, with an EBITDA margin of 8.35%.
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in Kuros Biosciences Ltd. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in Kuros Biosciences Ltd. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 31.98 CHF and 37.74 CHF for KURN, based on current estimates.
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
